Boston University
Development of carbohydrate-based materials as targeted therapeutics and biomimetics
Abstract
dc:description.abstractPolysaccharides are an important class of biomacromolecules with relevance in numerous biological processes. Polysaccharides are biodegradable and biocompatible with dense hydroxyl functionalities giving rise to their popularity within translational research. Native polysaccharides often employed for therapeutic systems are isolated from biological sources resulting in structural heterogeneity, widely dispersed molecular weights, and residual biological contaminants. The batch-to-batch inconsistency inherent to isolated polysaccharides has prompted the development of synthetic polysaccharide mimetics to access well controlled polymeric structures for the development of improved therapeutics. To this end, polyamidosaccharides (PASs), which contain α-1,2 amide linkages replacing native glycosidic bonds between the repeating sugar units, are accessed via an anionic ring-opening polymerization of a fused bicyclic β-lactam monomer. Utilizing the PAS design, new polysaccharide mimetics are reported for applications in translational research. Amphiphilic polysaccharides have potential in drug delivery due to nanoparticle self-assembly and applications as biosurfactant mimetics. Through the use of fatty acid derived polymerization initiators with varied alkyl chain lengths, a library of amphiphilic fatty acid PASs with molecular weight control are described. The polymers are helical in secondary structure with decomposition occurring above 240°C and self-assemble into nanostructures. The polymers exhibit decreasing surface tension with decreased polymer chain lengths and C14 alkyl fatty acid chains to demonstrate their use as glycolipid biosurfactants. Hyaluronic acid (HA) targets the transmembrane glycoprotein, CD44, which is upregulated on numerous cancer cell types. Due to the tumor targeting ability of HA, therapeutic systems have been reported; however, native HA suffers from heterogeneity, biological contaminants, and is readily degraded by increased levels of hyaluronidase present within the tumor microenvironment. Thus, synthetic mimetics that retain CD44 binding are of interest. Polymerization of a novel β-lactam monomer derived from the β-(1→4)-disaccharide repeating unit of HA and subsequent post-polymerization modifications afford a novel HA mimetic. The mimetic binds CD44 with micromolar affinity, is non-cytotoxic, and is resistant to hyaluronidase degradation. In a contrasting approach, the preparation of an azido-armed β-(1→4)-disaccharide conjugated to a PAS backbone via a strain-promoted azide-alkyne cycloaddition affords branching PASs. The polymer library composed of both homopolymers and copolymers bear 3-27% disaccharide conjugation relative to the polymeric backbone. Polymers with the highest conjugation efficiency bind CD44 with nanomolar affinity and are not cytotoxic. Confocal microscopy reveals a rhodamine-labelled polymer is internalized by CD44-expressing breast cancer cells. When paclitaxel is conjugated to the polymer, cell viability is significantly decreased as compared to paclitaxel alone in breast cancer cells highlighting the targeted therapeutic potential of this system.
Degree
thesis:*- Name thesis:degree_name
- Doctor of Philosophy
- Level thesis:degree_level
- doctoral
- Discipline thesis:degree_discipline
- Chemistry
- Grantor
- Boston University
- Year dc:date.issued
- 2026
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Sockett, Kaitlynn A.
- Advisor dc:contributor.advisor
-
- Grinstaff, Mark W.
- ORCID dc:identifier.orcid
Subjects
dc:subject × 7Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53697